Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Geburtshilfe Und Frauenheilkunde|October 1, 1986
[Perioperative antibiotic prevention with cefoxitin in cesarean section. Management and uses]F Fischbach, W Loos, R Thurmayr, et al.Fortschritte Der Medizin|October 20, 1994
[Blood transfusion in surgical gynecology. Strategies for preventing homologous blood transfusion]W Loos, W Kuhn, A Prechtl, et al.Journal of Chromatography|June 2, 1993
Sensitive isocratic high-performance liquid chromatographic determination of a novel indoloquinone cytotoxic drug (EO9) in human plasma and urineJ H Schellens, W Loos, J H Beijnen, et al.Geburtshilfe Und Frauenheilkunde|October 1, 1983
[Accuracy and practicability of the Prevical curette for the early diagnosis of endometrial carcinoma]F Fischbach, H P Krieglsteiner, W Loos, et al.Der Anaesthesist|April 1, 1976
[Haemodynamics, oxygen demand and oxygen uptake of the heart during isovolaemic haemodilution (author's transl)]D Kettler, K Hellberg, G Klaess, et al.Der Anaesthesist|April 1, 1976
[Haemodynamics and tolerance to hypoxia of the myocardium under 6%-oxygen ventilation following acute isovolaemic haemodilution in experimental animals (author's transl)]W Loos, K Kettler, K Hellberg, et al.Behaviour Research and Therapy|May 1, 1995
Effects of varying scoring rules of the Clinician-Administered PTSD Scale (CAPS) for the diagnosis of post-traumatic stress disorder in motor vehicle accident victimsE B Blanchard, E J Hickling, A E Taylor, et al.Geburtshilfe Und Frauenheilkunde|July 1, 1988
[Puerperal ovarian vein thrombophlebitis--a rare puerperal complication]W Loos, R von Hugo, W Rath, et al.British Journal of Cancer|September 29, 2004
Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1-5 of a 3-weekly cycle in patients with advanced solid tumoursM J A de Jonge, S Kaye, J Verweij, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Phase II and pharmacologic study of topotecan administered as a 21-day continuous infusion to patients with colorectal cancerG J Creemers, C J Gerrits, J H Schellens, et al.Pageof 3